Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Catastrophic Claims Often Require Nuanced Solutions
In workers’ compensation, catastrophic injuries transpire with relatively low frequency.
Mitchell
News Release
Mitchell Diagnostics Platform Surpasses 3 Million Scans
SAN DIEGO, CA—November 3, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
Mitchell
News Release
Mitchell Named Official Technology Provider of the Vale Paintless Dent Repair (PDR) Technician Certification Program
SAN DIEGO, CA—October 26, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
Enlyte
Article
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
Enlyte
Article
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
PDF
Article
Specialty Services Are a Big Deal
When adjusters have to jump through hoops to make referrals, they lose precious time.